Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study (Q36859528)
Jump to navigation
Jump to search
scientific article published on 25 June 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study |
scientific article published on 25 June 2015 |
Statements
1 reference
Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study (English)
1 reference
Philipp von Rosenstiel
1 reference
Hans-Peter Hartung
1 reference
Ludwig Kappos
1 reference
Frederik Barkhof
1 reference
Giancarlo Comi
1 reference
Shannon Ritter
1 reference
Bhupendra Khatri
1 reference
Xavier Montalban
1 reference
Tracy Stites
1 reference
Davorka Tomic
1 reference
Jeffrey A Cohen
1 reference
Jean Pelletier
1 reference
TRANSFORMS (TRial Assessing injectable interferoN vS. FTY720 Oral in RRMS) Study Group
1 reference
25 June 2015
1 reference
1 reference
468-475
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference